Close

UPDATE: Statera Biopharma (STAB) Receives Nasdaq Delisting Decision, Scheduled Hearing for October 6

Go back to UPDATE: Statera Biopharma (STAB) Receives Nasdaq Delisting Decision, Scheduled Hearing for October 6

Statera Biopharma (STAB) Resumes Trading

September 27, 2022 12:25 PM EDT

Statera Biopharma (NASDAQ: STAB) Resumes Trading

... More

Statera Biopharma (STAB) Halted, News Pending

September 27, 2022 9:14 AM EDT

Statera Biopharma (NASDAQ: STAB) Halted, News Pending

... More